Argenica Therapeutics Ltd Ordinary Shares AGNTF
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Argenica Therapeutics Ltd is engaged in the development and commercialization of novel drug candidates. Its ARG007 drug improves outcomes in pre-clinical stroke models and is in the process of being verified for its safety and toxicology before commencing Phase 1 clinical trials in humans.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- https://www.argenica.com.au
Valuation
Metric
|
AGNTF
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric
|
AGNTF
|
---|---|
Quick Ratio | 4.23 |
Current Ratio | 4.25 |
Interest Coverage | — |
Quick Ratio
AGNTF
Profitability
Metric
|
AGNTF
|
---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
AGNTF
Biotechnology Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Jftwchsf | Vqln | $605.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Rlhwtxtl | Bmrxhvj | $116.3 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Mzfkwtq | Qgjscfn | $108.5 Bil | |
MRNA
| Moderna Inc | Wsxxxqtj | Dplx | $62.9 Bil | |
BNTX
| BioNTech SE ADR | Bcmrjhph | Xckw | $23.9 Bil | |
ARGX
| argenx SE ADR | Bycrsrwl | Kjfj | $21.6 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Qzjrhjv | Pzttqy | $18.9 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Dbhnmrtp | Ldfxxk | $14.3 Bil | |
INCY
| Incyte Corp | Dljxsfd | Tlwzyc | $12.9 Bil | |
UTHR
| United Therapeutics Corp | Sbwrjpfz | Bvcv | $12.1 Bil |